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Abstract
Analysing the pathogenic mechanisms of a bacterium requires an understanding of the composition of the bacterial cell
surface. The bacterial surface provides the first barrier against innate immune mechanisms as well as mediating attachment
to cells/surfaces to resist clearance. We utilised a series of Klebsiella pneumoniae mutants in which the two major
polysaccharide layers, capsule and lipopolysaccharide (LPS), were absent or truncated, to investigate the ability of these
layers to protect against innate immune mechanisms and to associate with eukaryotic cells. The capsule alone was found to
be essential for resistance to complement mediated killing while both capsule and LPS were involved in cell-association,
albeit through different mechanisms. The capsule impeded cell-association while the LPS saccharides increased cell-
association in a non-specific manner. The electrohydrodynamic characteristics of the strains suggested the differing
interaction of each bacterial strain with eukaryotic cells could be partly explained by the charge density displayed by the
outermost polysaccharide layer. This highlights the importance of considering not only specific adhesin:ligand interactions
commonly studied in adherence assays but also the initial non-specific interactions governed largely by the electrostatic
interaction forces.
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Introduction
The physicochemical composition of the bacterial cell surface is
an important factor in bacterial pathogenicity, since it is this
surface that first interacts with soluble factors (eg. the humoral
immune system) and the extracellular matrices of the infected host
tissues and cells. Bacteria have evolved cell surface characteristics
arising from carbohydrate and protein charge and composition
under pressures exerted by their specific host environment. For
example, many bacteria display a polysaccharide ‘coat’, either as a
discrete layer of exopolysaccharide described as a capsule, or as a
loosely attached slime layer. Bacterial capsules may include
hyaluronic acid (eg. group A Streptococcus [1]) or sialic acid (eg.
Neisseria meningitidis [2]) residues which can mimic human cell
surfaces and thus reduce detection by the immune system.
Polysaccharide capsules may also potentially favour the attach-
ment to surfaces and the formation of biofilms through non-
specific forces such as electrostatic and van der Waals forces
and/or specific ligand-receptor interactions [3–5]. Capsules may
also provide a measure of resistance to dessication in the
environment [6].
Among the exopolysaccharides produced by gram-negative
bacteria is lipopolysaccharide (LPS) comprising three distinct
sections; lipid A, core and O-antigen (O-Ag) polysaccharide. The
lipid A anchors the LPS molecule into the outer membrane and is
also an endotoxin, stimulating the immune system through
agonism of Toll-like receptor 4 (TLR4) which is present on
macrophages, dendritic cells and other cell types. Agonism of
TLR4 leads to intracellular signalling through MyD88-dependent
and independent processes, inducing NF-kB mediated production
of cytokines [7]. The core region of LPS, which links the O-Ag
onto the lipid A molecule, contains a small number of mono-, di-
or oligosaccharides (including 2–3 3-deoxy-D-manno-octulosonic
acid (KDO) residues) and is negatively charged usually due to
phosphate substitutions. Finally, the O-Ag consists of a variable
number of saccharides repeated to form a polysaccharide layer
that extends up to 30 nm into the surrounding media [8,9].
In this study we investigated the cell surface properties of
Klebsiella pneumoniae, a bacterium ubiquitous in nature, being
present in the soil, surface water and often as normal
gastrointestinal flora [10–12]. K. pneumoniae is also a human
pathogen and is found with increasing frequency as a cause of
hospital acquired infection, especially in intensive care and
neonatal wards [13–15]. This bacterium possesses surface
saccharides in the form of LPS and capsule, both of which have
been linked with the virulence of K. pneumoniae in humans. Over
90% of clinical isolates from Denmark, Spain and the US were
found to be O-Ag positive, of which O1 was the most common
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Australia and Taiwan were capsule typeable (untypeable strains
may be unencapsulated or of a novel capsule type) [17,18].
The strain utilised in this study (B5055) is of the K2:O1
serotype. The K2 serotype repeat unit structure has been
determined as [19]:
?3)-b-D-Glcp-(1?4)-b-D-Manp-(1?4)-a-D-Glcp-(1?
3
;
1
a-D-GlcpA
And the O1 LPS serotype:
D-galactan II-b-Galf-D-galactan I?3)-a-Galp-?3)-
b-GlcNAc-(1?5)-a-Kdo-(2?6)-anhMan
where D-galactan I [R3)-a-Galp-(1R3)-b-Galf-(1], and D-galac-
tan II [R3)-b-Galp-(1R3)-a-Galp-(1], are repeating units [20].
Unlike many Enterobacteriaceae, the K. pneumoniae LPS core is not
phosphorylated and the negative charge of the core is instead
attributed to the presence of galacturonic acid (GalA) and KDO
residues. Therefore investigations of the function of LPS in the
commonly studied Enterobacteriaceae (eg. E. coli and Salmonella sp.)
should not be extrapolated to K. pneumoniae without experimental
confirmation.
In this study we generated mutations in wzb/c and in waaF of K.
pneumoniae strain B5055 in order to study the contribution of the
capsule and LPS saccharides to the surface structure and function
of K. pneumoniae. We then examined the biological and physico-
chemical consequences of these changes to virulence. The results
suggested that while capsular polysaccharides were essential for
resisting innate immune mechanisms, the saccharides present in
LPS may play a role in maintaining a neutral surface charge to
allow association with the host cell to occur.
Results
Characterisation of saccharide mutants
To assess the contribution of saccharides to K. pneumoniae
virulence, mutations in wzb-c or waaF were successfully created in
K. pneumoniae B5055 to produce an unencapsulated mutant (Dwzb-c,
B5055nm) and an unencapsulated, ‘‘deep-rough’’ LPS mutant
(DwaaF,B 5 0 5 5 n m waaF). B5055waaF was also created but this strain
appeared phenotypically unencapsulated; recent evidence indicates
that ‘‘deep-rough’’ LPS mutants are unable to retain cell-associated
capsule [21,22] and therefore this strain was not used for in vitro
assays. B5055, B5055nm and B5055nmwaaF were characterised for
the presenceof capsulebyManeval’s staining anduronicacid assays,
and for LPS O-Ag by silver staining and immunofluorescence with
an O1-Ag specific mAb (Fig. 1). The capsule was visualised in
preparations of the wild type B5055, but not in B5055nm and
B5055nmwaaF (Fig. 1a); the amount of uronic acid, present as
glucuronic acid in the capsule and galacturonic acid in the LPS, was
reduced at least 10-fold for both mutant strains.
Proteinase K-digested whole cell lysates were separated by SDS-
PAGE and LPS visualised by modified silver staining [23]. LPS O-
Ag was observed in wild-type B5055 and unencapsulated
B5055nm preparations, but not in the double mutant
B5055nmwaaF (Fig. 1b). The only proteinase K-resistant structure
seen in this strain appeared to be the lipid A/core molecule, which
migrated faster in SDS-PAGE than wild-type core, following the
loss of the majority of core saccharides. Fluorescent microscopy
and fluorescent activated cell sorter (FACS, Fig. 1c) analyses using
a monoclonal antibody (mAb) previously determined to be specific
to the O1-Ag of K. pneumoniae (designated mAb C13) indicated that
both B5055 and B5055nm expressed the O1-Ag on the cell surface
while B5055nmwaaF showed no reactivity with this antibody
indicating the O1-Ag is not expressed on the cell surface of this
strain. FACS and microscopic analysis both indicated agglutina-
tion of the O-Ag positive, capsule negative strains (B5055nm and
B5055nmwaaF (pBRwaaF)) with mAb C13. As a result FACS
fluorescence analysis was restricted to single cells as gated in the no
primary antibody controls for each bacterial strain. Growth rates
of the three strains were compared in Luria broth and Dulbecco’s
Modified Eagle Medium (DMEM supplemented with L-glutamine
and 10% FCS) and found to be equivalent (data not shown).
Outer membrane proteins (OMPs) were purified from each
strain and compared by 1D SDS-PAGE (Fig. 1d). OMPs prepared
from mid-log cultures showed identical banding patterns for all
strains. Previous studies have found trimerisation of some OMPs
(such as OmpF and C) to be reduced in deep rough LPS mutants
[24]. While this may be occurring in B5055nmwaaF the identical
protein profile suggests this is not leading to a loss of any proteins
(including potential adhesins) in the outer membrane.
Resistance to innate immune mechanisms
The exopolysaccharide capsule is important in resistance to
phagocytosis and/or complement-mediated lysis of K. pneumoniae
[25,26], while the O-Ag of LPS has been implicated in resistance
to complement-mediated lysis [27,28]. However, differing results
for various strains has led to some doubt over these designations
and we therefore analysed resistance of B5055, B5055nm and
B5055nmwaaF to these innate defence mechanisms.
Complement-mediated lysis assays were conducted both in the
presence and absence of tetracycline (a bacteriostatic antibiotic) in
order to determine whether complement factors in the serum were
bactericidal, rather than bacteriostatic. The viable counts of
unencapsulated mutants (ie. B5055nm, B5055nmwaaF and
B5055nmwaaF (pBRwaaF)) were all reduced by ,3 logs within
the initial 30 minute incubation indicative of killing by comple-
ment factors present in human serum (Table 1), suggesting that
capsule is necessary for resistance to complement-mediated lysis.
With FACS analysis having shown the O1-Ag is present on the
bacterial cell surface of B5055nm, the inability of this strain to
resist killing by complement factors suggested that the O1-Ag of
LPS was unable to protect the bacterial membrane from killing by
complement-mediated effectors. Whole blood phagocytosis assays
[29] showed the same pattern as the complement-mediated lysis
assays, suggesting that complement killing is an important innate
immune mechanism in controlling septicemic K. pneumoniae.
Cell-association properties
Another important process in the establishment of a bacterial
infection is the ability of the bacteria to associate with host cells,
initially through surface adhesion [30]. Cell association is
important simply to resist clearance (eg association with lung
epithelial cells allows resistance of mucocilliary clearance), and
thus facilitates colonisation and then pathology. The K. pneumoniae
capsule has previously been implicated in impeding adherence to
cells by physically shielding short adhesins, negating their function
[31,32]. We investigated the ability of our bacterial strains to
associate with a mouse macrophage-like cell line (RAW264.7), and
a human lung epithelial cell line (A549).
Bacterial Surface Saccharides
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increased cell association (greater than 10-fold) to both cell lines
compared with the wild type capsulated strain, confirming
previous findings that the capsule reduces bacterial adherence
[31,33] (Fig. 2a and b). Although there was much higher cell-
association overall to RAW cells (likely due to the phagocytosis/
internalisation of bacteria by this macrophage-like cell line), the
relative increase in cell-association that occurred following
removal of the capsule was similar in the two cell types.
If the increased cell-association of the unencapsulated B5055nm
was due simply to exposure of short proteinaceous adhesins, we
hypothesised that bacteria lacking both LPS and capsular exopoly-
Figure 1. Characterisation of the surface layers of K. pneumoniae mutant strains. A) The capsule was visualised by Maneval’s stain and
quantified by uronic acid assay. UD=undetectable. B) LPS preparations were separated by SDS-PAGE on a 15% polyacrylamide gel and visualised by
modified silver staining. C) Fluorescent activated cell sorting using mAb C13 specific for the O1-Ag of LPS. Only single cell populations (determined
from cells stained with secondary antibody alone) were included in fluorescence analsyis. D) OMP preparations from mid-log cultures separated by
12.5% SDS-PAGE and visualised by Coomassie Brilliant Blue staining. Lanes are (1) B5055, (2) B5055nm, (3) B5055nmwaaF and (4)
B5055nmwaaF+pBRwaaF.
doi:10.1371/journal.pone.0003817.g001
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B5055nmwaaF showed decreased cell-association compared with
B5055nm. This decrease was approximately 5-fold for A549 cells
and approximately 10-fold for RAW cells (Fig. 2a and b). The wild
type level of association was restored in the complemented strains
confirming the effect was due to the absence of the LPS
polysaccharides rather than a secondary mutation. Cell-association
experiments with A549 cells were repeated omitting the centrifuga-
tion step with no alteration of results.
The phenomonen of bacterial adhesion can be separated into 2
major processes; long range electrostatic interactions that allow a
bacterium to come into contact with the cell/substrate etc; and
short range specific adhesin interactions. Therefore we investigat-
ed whether the decreased cell-association of B5055nmwaaF was a
direct consequence of the loss of an LPS adhesin, ie. whether the
O-Ag could act as an adhesin per se, or whether the reduced cell-
association was an indirect effect resulting from altered electro-
chemical properties, affecting long-range interactions between the
bacteria and the eukaryotic cell membrane.
O-Ag of LPS as an adhesin
Two methods wereutilised to determine whetherLPS saccharides
were directly acting as an adhesin. Firstly purified LPS, either intact
or saccharides alone (acetic acid treated) were used to competitively
inhibit LPS-mediated association with cells [34]. If specific LPS-
A549 interactions were occurring free LPS molecules should adhere
to their specific A549 receptors reducing the available binding sites
for cell-bound LPS, and hence reducing the final cell-associated
bacterial count. Secondly Fab fragments of the mAb I12, which
specifically binds to the O1-Ag of LPS, were used to coat LPS
molecules on the bacterial cell surface prior to addition of the
bacteria to the cell association assay in order to prevent LPS-
mediated cell association. No difference in bacterial association was
observed with either treatment suggesting that the LPS saccharides
were not specifically acting as an adhesin for A549 cells.
Electrohydrodynamic characteristics of the bacterial
strains
The electrophoretic mobilities of B5055, B5055nm,
B5055nmwaaF and B5055nmwaaF (pBRwaaF) were measured over
a broad range of ionic strengths (Fig. 3). In general, the mobilities of
the bacteria decreased (in absolute value) when the ionic strength of
the buffer increased. This was due to masking of the bacterial charge
by the mobile electrolyte ions, as anticipated from classical electric
double layer theory. These results indicate that the nature of the
bacterial surface ultrastructure impacts significantly on the magni-
tude of the mobility of the bacterium, a phenomenon that is
dependent on the ionic environment. The electrophoretic mobilities
of bacteria which present LPS O1-Ag as the outermost layer (ie.
B5055nm) were significantly lower than the mobilities of bacteria
devoid of O-Ag (ie. B5055nmwaaF). The ionic strength-mobility
patterns were also significantly different for these two strains. The
presence of K2 capsule for the wild type encapsulated B5055 led to
an intermediate electrokinetic response as compared to that for
B5055nm and B5055nmwaaF. The complemented strain,
B5055nmwaaF (pBRwaaF) fully recovered the electrokinetic features
of the unencapsulated mutant (B5055nm).
Table 1. Resistance of K. pneumoniae strains to complement
mediated lysis.
Strain
% survival (of inoculum) 60 min after
incubation with sera
B5055 142
B5055+HTS* 105
B5055nm 0.0021
B5055nm+HTS* 107
B5055nmwaaF 0.0018
B5055nmwaaF+HTS* 106
B5055nmwaaF+pBR-waaF 0.012
B5055nmwaaF+pBR-waaF+HTS* 50
*HTS=Heat treated sera. Serum complement factors were inactivated by
heating at 56uC for 30 min.
Note: A bacteriostatic antibiotic - tetracycline (25 mg/ml) - was added to
samples to inhibit growth and hence allow direct measurement of bacterial
killing by complement factors.
Figures are the average of duplicate samples, and the assay has been repeated
in the presence and absence of tetracycline.
doi:10.1371/journal.pone.0003817.t001
Figure 2. Association of K. pneumoniae mutant strains to mammalian cells. Bacteria were cultured to mid-log growth phase, washed, and
added to confluent monolayers of RAW264.7 macrophage-like cells (A) or A549 epithelial cells (B). After 2 hrs, non-adherent bacteria were removed
by repeated washing, cells were treated with Triton X-100 and cell lysates were plated for CFU enumeration. The number of cell associated bacteria
are presented as the percentage of the initial inoculum. The data are the mean and standard deviation (SD) of 6 wells/strain and the assay was
repeated at least three times.
doi:10.1371/journal.pone.0003817.g002
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evaluate the electrohydrodynamic characteristics of the bacterial
interface.Thesecalculationswereusedtoaccountfortheexperimental
dataandinparticular,evaluatethevolumechargedensity(ro)andthe
flow penetration degree (lo
21) of the ‘‘soft’’ layer (the surface
ultrastructure) surrounding the bacteria, namely the capsule for
B5055 (160 nm thick), the LPS O1-Ag layer for B5055nm (30 nm
thick) and the outer membrane for B5055nmwaaF (2 nm thick). The
resulting best-fit calculations are shown in Fig. 4 and the relevant
parameters extracted from such analysis are collected in Table 2.
Quantitative evaluation of electrophoretic mobility of the
different strains allowed dissection of the electrostatic and
hydrodynamic interfacial properties of the bacteria [35–38]. The
electrophoretic mobility for B5055 and B5055nm was governed by
the physicochemical characteristics (electrostatic and hydrody-
namic) of the K2 capsule and LPS O1-Ag surface elements
respectively, as the thickness of those two layers exceed, by at least
an order of magnitude, the determined typical hydrodynamic
penetration lengths lo
21. Therefore, the analysis of the wild type
and modified bacterial strains enabled independent evaluations of
the electrokinetic features of these surface structures (capsule and
LPS). The unencapsulated B5055nm strain demonstrated signif-
icantly lower (1/10th) volume charge density and somewhat
higher hydrodynamic permeability compared to the encapsulated
B5055 strain. This suggested that the electrical charge resulting
from the very permeable LPS O1-Ag was significantly lower than
that from the K2 capsule and that although the K2 capsule layer
may be considered ‘‘soft’’ or permeable, the flow penetration into
the inner LPS O1- Ag surface element is more significant than that
into a K2 capsule layer. These results suggest that (i) the
glucuronic acid residue in the K2 capsule is responsible for the
volume charge density in B5055 and (ii) the thick K2 capsule
provides a hydrodynamic barrier that separates the inner bacterial
material from the outer electrolyte solution.
B5055nmwaaF, which lacks the O1-Ag surface layer and the K2
capsule, exhibited the largest volume charge density and the lowest
hydrodynamic permeability degree among the three analysed
bacterial strains. This was observed because electro-osmotic flow
probes a large number of charges (negatively charged core
saccharides (GalA, KDO) and outer membrane proteins) distrib-
uted within a confined volume layer (2 nm thick) located in close
proximity to the impermeable core of the bacterial surface
structure (i.e. the region where the friction exerted on fluid flow
is larger or, where the local hydrodynamic permeability is lower).
As outlined in previous analyses [39], the heterogeneity of the
interface is intrinsically related to the magnitude of the charge
density carried by the soft, flexible (deformable) part of the
bacteria, and to the hydrodynamic permeability of the bioparticle
(as determined by local steric hindrance to flow). In more detail,
the larger the ro and the lower the permeability, the larger the
interfacial osmotic pressure drop and the more heterogeneous the
polymer segment density distribution from the rigid core to the
outer periphery of the bacteria as a result of anisotropic water
uptake within the periphery, and the soft central component of the
bacteria. These theoretical trends are exactly those obtained for
the three bacterial strains examined here (see Table 2).
Discussion
Bacteria are constantly adapting to changing environments and
must balance any adaptations with the need to conserve energy
output. Therefore, high energy-requiring processes are likely to be
essential for bacterial survival in selected environments. The
production of both capsule and LPS are complex processes,
requiring high energy expenditure, and both structures are
therefore likely to be essential for a bacterium’s survival and/or
virulence. Both capsule and LPS appear to be constitutively
expressed at a basal level but can be upregulated and modified
where this is advantageous to survival of the organism [40–42].
Previous work has suggested that the K. pneumoniae capsule is
necessary for resistance to phagocytosis while the O-Ag is essential
for resistance to complement mediated lysis [27,28,43]. In the
current study however, we found that the capsule but not LPS was
Figure 3. K. pneumoniae CPS and LPS saccharides affect the electrophoretic mobility of the bacteria. The electrophoretic mobility of
B5055, B5055nm, B5055nmwaaF and B5055nmwaaF (pBRwaaF) were compared in different ionic strength potassium nitrate buffers at the natural pH
of the buffer (pH 5.5–6). Shown are the mean and SD of 60 trajectories for each strain, under each condition. The assay was repeated on different
days with fresh cultures.
doi:10.1371/journal.pone.0003817.g003
Bacterial Surface Saccharides
PLoS ONE | www.plosone.org 5 November 2008 | Volume 3 | Issue 11 | e3817Bacterial Surface Saccharides
PLoS ONE | www.plosone.org 6 November 2008 | Volume 3 | Issue 11 | e3817essential for resistance to complement-mediated lysis. Confirma-
tion that the O1-Ag was present on the cell surface by FACS
analysis demonstrated that the O1-Ag saccharides alone on the
cell surface were unable to protect against lysis by complement,
further validating findings that the capsule modulates C3
deposition [26]. Our results confirmed the necessity of capsule
production for K. pneumoniae survival and virulence in mammalian
hosts but raised questions as to the role of the LPS saccharides if
they were not involved in resistance to complement mediated lysis.
The importance of the O-Ag to K. pneumoniae is inferred by its
presence in over 90% of clinical isolates, the most common
serotype of which is O1 [16,44], suggesting an advantage to
producing this serotype over other O types.
While investigating the ability of strains to be phagocytosed by a
murine macrophage-like cell line (RAW264.7), we observed that
B5055nmwaaF, the strain lacking both capsule and LPS, had
decreased association with these cells compared to the unencap-
sulated but O1-Ag positive strain, B5055nm. The increased cell-
association of unencapsulated B5055nm compared to encapsulat-
ed B5055 has previously been attributed to the ability of the
capsule to physically shield short adhesins [31,32]. As such, it
would be expected that further exposing these adhesins by removal
of the LPS saccharide layer would again increase adherence.
However, in this study we found that LPS contributed to long
range electrostatic interactions rather than short range adhesin-
specific processes. Investigation of the volume charge density of
these strains confirmed a high negative charge density on the
surface of B5055nmwaaF, which we propose interfered with long
range interactions by significantly increasing the repulsive
electrostatic forces between the eukaryotic and bacterial cells.
This would lead to decreased association of B5055nmwaaF with
eukaryotic cells, regardless of the presence of specific adhesins
since the bacteria and eukaryotic cells would not be in close
enough proximity to allow specific interactions to be engaged.
From these studies we conclude that one function of the O-Ag
of K. pneumoniae involves presentation of a neutrally charged surface
to the host. This supports previous hypotheses by Walker et al that
long uncharged O-Ags of E. coli K12 shielded the charged groups
of the bacterial membrane thus increasing bacterial interaction
with quartz surfaces [45]. One outcome of this charge ‘masking’
would be to overcome long-range repulsion between bacteria and
eukaryotic cells allowing specific adherence to occur. In addition,
there are likely to be other consequences of this function such as a
reduction in binding of charged particles, eg. antimicrobial
peptides, to the bacterial cell surface. The lung defensin SP-D
interacts with core LPS sugars but has been shown to be ineffective
against O1-Ag positive K. pneumoniae strains [46]. This may result
in part from steric hindrance, however the inability to detect the
charged core region due to the presence of neutral O1-Ag may
also contribute to this reduced efficacy. Therefore although we
have demonstrated one important outcome of removing the
neutral O1-Ag charge, namely decreased cell association, there
may be other consequences which would make expression of the
neutral O1-Ag advantageous for virulence in K. pneumoniae.
Methods
Bacterial strains and plasmids
The K. pneumoniae strain used was B5055, a mouse virulent
clinical isolate (serotype K2:O1) and a non-encapsulated mutant of
B5055 designated B5055nm, produced by Dr T. Uren and Dr A.
Jenney (Department of Microbiology and Immunology, University
of Melbourne) through the inactivation of wzb and wzc. Briefly a
1.1 kb HindIII fragment spanning wzb and wzc was removed and a
1.6 kb HindIII fragment from pUC4KIXX containing the
kanamycin resistance cassette inserted. Genomic recombination
was achieved by electroporating the linear wzb-kan-wzc fragment
into B5055 containing induced l red recombinase and selecting
for kanamycin resistant mutants. E. coli JM109 and the plasmids
pGEM T-Easy or pBR322 (Promega) were used for cloning
experiments. The temperature sensitive plasmid pKD46 [47] was
used to induce l red recombinase production in the host cell in
order to enhance homologous recombination. Bacteria were
grown in Luria broth (LB) or on Luria agar (LA) at 37uC (except
for induction of l red recombinase when bacteria were cultured at
30uC). Antibiotics were used at the following concentrations:
ampicillin at 100 mg/ml, kanamycin at 60 mg/ml and chloram-
phenicol at 30 mg/ml.
Generation of K. pneumoniae waaF mutant
The waa operon of B5055 was sequenced and determined to be of
the core 2 serotype [48]. The second gene in the operon, the waaF
gene (plus 500 bp at either end of the open reading frame) was
amplified from B5055 using oligonucleotide primers (59-GGAAGC-
CAATTCGCAGATCG-39 and 59-GCTTTTGGCGAACAGCT-
CAC-39) and cloned into pGEM T-Easy (to form pGEM-waaF),
followed by digestion with XmaI and StuI to remove a central 362
bp fragment. A chloramphenicol resistance cassette (cat)f r o m
pACYC184 was amplified with primers 59-GATCACCCGGGG-
TAGCACCAGGCGTTTAAGGG-39 and 59-ACTGTAGGCCT-
CGTAAGAGGTTCCAACTTTCAC-39 and cloned into pGEM-
waaF using the underlined XmaI and StuI sites (to form pGEM-
waaF/Chl). pKD46 was electroporated into B5055 (2.5 kV, 25 mF,
200 V) or B5055nm (1.8 kV, 25 mF, 200 V) and grown at 30uC with
L-arabinose to induce l red recombinase production. The waaF-Chl
fragment was then amplified as a 2.5 kb linear fragment, gel purified
and digested with NotI to remove any residual intact plasmid. The
linear DNA fragment was electroporated into B5055+pKD46 or
B5055nm+pKD46 and grown at 37uC on chloramphenicol to
Table 2. Relevant electrokinetic parameters extracted from
the soft particle analysis.
Strain ro (mM) lo
21 (nm) a (nm)
B5055nm 22.8 3.85 0
B5055 222 2.3 3.5
B5055nmwaaF 2180 0.75 1–3
ro=volume charge density (or electrochemical charge).
lo
21=flow penetration degree.
a=degree of heterogeneity (or diffuseness) for the spatial distribution of the
permeable-soft layer.
doi:10.1371/journal.pone.0003817.t002
Figure 4. Theoretical description of the experimental electrophoretic mobilities of K. pneumoniae strains. The electrophoretic mobility
(filled circles) are graphed for A) B5055nm, B) B5055 and C) B5055nmwaaF K. pneumoniae strains expressed as a function of ionic strength. The
calculations were performed either by using a homogeneous description for the spatial distribution of the soft-permeable polymer (a=0, dash lines)
or using a heterogeneous distribution (a.0, dotted lines) to reproduce the experimental data over the whole range of ionic strength considered. The
different parameters obtained from the best fitting procedure are indicated in Table 1.
doi:10.1371/journal.pone.0003817.g004
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anticipated disrupted waaF gene size was confirmed by PCR and
confirmed recombinants designated B5055waaF and B5055nmwaaF
(for capsulated and unencapsulated strains respectively). Comple-
mentationwasachievedwithtwoconstructspGEM-waaoperon(where
the entire waa operon, including the native promoter was inserted
into pGEM T-EASY) and pBRwaaF (where the waaF open reading
frame was inserted such that it was transcribed from the lacZ
promoterofpGEM,andtranslatedfromthenativeAUGstartcodon
using the cognate waaF ribosome binding site and then amplified
with 59-CCGGAATTCGTCCATTCGCCATTCAGG-39 and 59-
CCGGGATCCGAGCGAGGAAGCGGAAGAG-39 and inserted
into pBR322). Not all mutants were able to be complemented and
only strains that could be complemented were used for further
studies.
Monoclonal antibody preparation
Themonoclonalantibodies C13 and I12were producedfollowing
immunisation of BALB/c mice with the sarkosyl insoluble outer
membrane protein fraction of B5055nm. The spleen cells from these
immunised animals were fused with non-secretory BALB/c
myeloma Sp2/0-Ag14 using 50% w/v polyethylene glycol (Sigma
Hybridoma Starter Pack, Sigma, Castle Hill, NSW Australia)
essentially as described previously [49]. Following fusion, screening
andsub-cloning,hybridomasupernatantswerepurifiedbyproteinG
sepharosecolumns (Sigma). C13 and I12weredetermined tobind to
the O1-Ag of B5055 by western blot and ELISA against purified
LPS (results not shown). FAb fragments of I12 were produced by
digestion on immobilised papain (Pierce) and purification on a
protein A sepharose column (Pierce).
SDS-PAGE analysis of LPS
Crude LPS preparations were made by pelleting cells from 3 ml
of overnight (o/n) cultures. The pellets were resuspended in
Laemmli buffer (2.3% SDS, 0.8% Tris, 10% glycerol, 5% DTT)
and samples boiled for 10 minutes. Samples were digested with
proteinase K (0.417 mg/ml) for 2 h at 56uC. SDS-PAGE was
performed on 15% polyacrylamide gels [50] and stained with
alkaline silver stain to visualize LPS [23].
Purification of LPS
LPS was purified by modified hot phenol extraction [51].
Stationary phase cultures (500 ml) were pelleted and washed with
PBS. The bacterial pellet was resuspended in a small volume of
PBS and cells disrupted by sonication. Debris was removed by
centrifugation at 5,4006g for 45 min and the supernatant
centrifuged for 1 hr at 16,0006g. The resulting pellet was
resuspended in 500 ml of 2 mM Tris-HCl, pH 7.8 and treated
with DNase and RNase for 2 hr at 37uC followed by Proteinase K
treatment for 2 hr at 56uC. Samples were heated to 65uC, mixed
1:1 with pre-heated phenol and incubated for 15 min at 65uC.
Samples were then cooled to room temperature and centrifuged to
separate the phases. The aqueous phase containing purified LPS
was removed and the phenol phase re-extracted with water.
The lipid A was cleaved from the LPS preparation by 1% acetic
acid treatment at 100uC and removed by centrifugation. All LPS
preparations were dialysed against water or PBS prior to use.
Extraction and quantification of capsule
Cell associated capsule was extracted from mid-log and static
cultures by the phenol-extraction method [51]. Briefly, 5 ml
samples were centrifuged (5000 g, 15 min, 4uC), washed,
resuspended in 500 mld H 2O and viable counts determined.
Samples were then incubated at 68uC for 2 min before addition of
500 ml phenol, incubation was then continued for 30 min. The
mixture was cooled and 500 ml chloroform added, centrifuged and
the aqueous phase collected. Capsular material was precipitated at
220uC for 20 min and resuspended in 500 mld H 2O.
Uronic acid content was determined as previously described
[52]. Briefly, 1.2 ml of 12.5 mM tetraborate in concentrated
H2SO4 was added to 200 ml sample and vortexed vigorously.
Samples were then boiled for 5 min and cooled before addition of
20 ml 0.15% 3-hydroxydiphenol in 0.5% NaOH. Absorbance was
measured at 520 nm. Standard curves were constructed with
glucuronic acid.
Bacterial capsules were also visualized by Maneval’s stain [53].
OMP preparation and analysis
OMPs were prepared from mid-log cultures by sarkosyl
separation [54]. Brifely bacteria were grown to mid-log (2.5 hrs
with shaking), pelleted, resuspended in 10 mM HEPES and
disrupted by sonication. Unbroken cells were removed by
centrifugation and membrane proteins (inner and outer mem-
branes) pelleted by ultracentrifugation (150,000 g, 60 min, 4uC).
Inner membrane proteins were solubilized in 1% N-lauroylsarco-
sine and insoluble outer membrane proteins collected by
ultracentrifugation (120,000 g, 40 min, 4uC).
OMPs were then analysed on 12.5% SDS-PAGE followed by
coomassie staining (20 mg protein per lane) or western blot (5 mg
protein per lane).
Cell association Assay
RAW 264.7 (murine macrophage-like) or A549 (human lung
epithelial type II) cells were seeded at ,2.5610
5cells/well in a 24
well tissue culture plate (Nalge Nunc International) and grown to
confluence (approximately 18 h) at 37uC, 5% CO2. Bacteria
grown to mid-log phase at 37uC with shaking were washed once
with PBS and resuspended in RPMI or DMEM (without
supplements) as appropriate. Tissue culture cells were washed
once with fresh media and 500 ml of the appropriate supplemented
media added. 100 ml of undiluted bacterial suspension was added
to each well and a sample retained to determine the inoculation
dose. Plates were centrifuged at 5006g for 5 min to increase
interaction of bacteria and cells and incubated for 2 h at 37uC, 5%
CO2. Wells were washed three times with fresh media and 100 ml
0.1% Triton X-100 added for 10 min at RT to lyse the eukaryote
cell membranes. 400 ml LB was added to the wells and the number
of viable bacteria determined by culturing on selective media.
Results were expressed as mean and standard variation and
statistical difference assessed by unpaired two-tailed student t-test.
Electrophoretic mobility measurements
Bacteria were grown sequentially on LA o/n, in LB o/n and
finally to mid-log in 50 ml LB. Bacteria were pelleted (10 min,
10,0006g), washed once with 1 mM KNO3 and resuspended in
1 mM KNO3 at ,10
7 cfu/ml. Electrophoretic mobility measure-
ments were then performed (Zetaphoremeter IV, CAD Instru-
mentations, Les Essarts le Roi, France) in a quartz suprasil cell at
room temperature (22–24uC). The bacterial mobilities were
measured by reflection of a laser beam and tracked with a
charge-coupled device camera. Image analysis software allowed
recorded images to be processed in real time to calculate the
electrophoretic mobilities from the displacement of bacteria
subjected to a constant direct-current electric field (800 V/m).
Different cycles were performed and 60 mean bacterial trajectory
was obtained for each condition. All the experiments were carried
out in natural pH (,6) and repeated twice with different cultures.
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The dependence of the electrophoretic mobilities on the ionic
strength was analysed as recently described (Duval et al. 2006).
Briefly, the electrokinetic response of the bacteria was assimilated
to that of a soft particle composed of an impermeable hard-core
component covered with a permeable polyelectrolyte layer. The
bacterial cells were modelled as soft spherical entities (microscopic
analysis indicated this strain grew as short bacilli, more closely
resembling a sphere than a rod-shape) of core radius equal to 1 mm
and the thickness (d) of the permeable layer was estimated at
160 nm for B5055 [55], 30 nm for the B5055nm [8,9] and 2 nm
for the B5055nmwaaF strain [56]. The experimental data were
fitted using the method of least mean squares to determine (i) the
permeability degree of the bacteria, as reflected by the typical
length (lo
21) of flow permeation within the charged polyelectrolyte
layer, (ii) the volume charge density (ro) of the soft permeable
component of the bacteria and (iii) the degree of heterogeneity/
diffuseness (subsumed in a parameter denoted as a) for the charged
polymer segment density distribution within the soft layer. For
sufficiently high electrolyte concentrations and/or low volume
charge layer densities, the electrohydrodynamic features of the
bacteria are essentially independent of the spatial distribution of
the soft material density at the bacteria/aqueous solution interface,
basically converting to homogeneous step-function like bacterial
interfaces (a=0). This peculiarity allows a practical determination
of the parameter (lo
21) and the volume charge density (ro). Any
deviations of theoretical predictions from the experimental data
(eg. at low ionic strengths) were quantitatively interpreted by
adjustment of the diffuse character (a) of the interface bacteria/
electrolyte solution. This increase of interfacial heterogeneity with
lowering electrolyte concentration is the result of swelling
processes partly due to large intramolecular repulsive forces within
the polymer.
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